Control of HAS3 Expression in IBD Patients as a Potential Target for Drug Therapeutics

Control of HAS3 Expression in IBD Patients as a Potential Target for Drug Therapeutics
A recent study entitled “Hyaluronan Synthase 3 Null Mice Exhibit Decreased Intestinal Inflammation and Tissue Damage in the DSS-Induced Colitis Model” was published in the International Journal of Cell Biology by Sean P. Kessler and colleagues from the Department of Pathobiology, Lerner Research Institute Cleveland Clinic, Cleveland, USA.  In the study, researchers suggest that the control

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *